Published by Josh White on 22nd March 2021
(Sharecast News) - Clinical-stage drug development company Evgen announced on Monday that Helen Kuhlman had been appointed to the post of chief business officer, taking up the role from 1 April.
URL: http://www.digitallook.com/dl/news/story/31723080/...